Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Prolonged adaptive immune activation in COVID-19: implications for maintenance of long-term immunity?
Philip A. Mudd, Kenneth E. Remy
Philip A. Mudd, Kenneth E. Remy
Published October 26, 2020
Citation Information: J Clin Invest. 2021;131(1):e143928. https://doi.org/10.1172/JCI143928.
View: Text | PDF
Commentary Article has an altmetric score of 26

Prolonged adaptive immune activation in COVID-19: implications for maintenance of long-term immunity?

  • Text
  • PDF
Abstract

Ongoing observational clinical research has prioritized understanding the human immune response to SARS-CoV-2 during the coronavirus disease 2019 (COVID-19) pandemic. Several recent studies suggest that immune dysregulation with early and prolonged adaptive immune system activation can result in cellular exhaustion. In this issue of the JCI, Files et al. compared cellular immune phenotypes during the first two months of COVID-19 in hospitalized and less severe, non-hospitalized patients. The authors utilized flow cytometry to analyze circulating peripheral blood mononuclear cells. Both patient cohorts maintained B and T cell phenotypes consistent with activation and cellular exhaustion throughout the first two months of infection. Additionally, follow-up samples from the non-hospitalized patient cohort showed that activation markers and cellular exhaustion increased over time. These findings illustrate the persistent nature of the adaptive immune system changes that have been noted in COVID-19 and suggest longer term effects that may shape the maintenance of immunity to SARS-CoV-2.

Authors

Philip A. Mudd, Kenneth E. Remy

×

Total citations by year

Year: 2025 2023 2022 2021 Total
Citations: 1 3 5 6 15
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2022 (5)

Title and authors Publication Year
Methylprednisolone Treatment Versus Standard Supportive Care for Adult COVID-19 Mechanically Ventilated, Acute Respiratory Distress Syndrome Patients
M Rahman, S Nair, M Din, M Dar, M Masood, A Menhali, M Nuaimi, J Sreedharan, H Gasmelseed, A Khan
2022
Stem cell therapy for COVID-19 pneumonia
M Kebria, P Milan, N Peyravian, J Kiani, S Khatibi, M Mozafari
2022
Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change
T Fulop, A Larbi, G Pawelec, A Cohen, G Provost, A Khalil, G Lacombe, S Rodrigues, M Desroches, K Hirokawa, C Franceschi, J Witkowski
Human vaccines 2022
COVID-19 disease and immune dysregulation
Davitt E, Davitt C, Mazer MB, Areti SS, Hotchkiss RS, Remy KE
Best practice & research. Clinical haematology 2022
Defective antifungal immunity in patients with COVID-19
Morton CO, Griffiths JS, Loeffler J, Orr S, White PL
Frontiers in immunology 2022

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 2 news outlets
Posted by 12 X users
50 readers on Mendeley
See more details